Reckitt Not Worried By Q4 Stumble At 'Jewel' OTC Business

As it felt the effects of a weaker cold & flu season, Reckitt insisted its subdued Q4 showing is not an indicator of how its Health business will perform in 2024. The unit is expected to deliver mid single-digit growth, as it did last year.